Related references
Note: Only part of the references are listed.Codon Usage and Adenovirus Fitness: Implications for Vaccine Development
Judit Gimenez-Roig et al.
FRONTIERS IN MICROBIOLOGY (2021)
Oncolytic viruses: what to expect from their use in cancer treatment
Maria Terrivel et al.
MICROBIOLOGY AND IMMUNOLOGY (2020)
Temporal dynamics of adenovirus 5 gene expression in normal human cells
Leandro Crisostomo et al.
PLOS ONE (2019)
A phase 1 dose escalation study of the oncolytic adenovirus enadenotucirev, administered intravenously to patients with epithelial solid tumors (EVOLVE)
Jean-Pascal Machiels et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2019)
Targeting the tumor stroma with an oncolytic adenovirus secreting a fibroblast activation protein-targeted bispecific T-cell engager
Jana de Sostoa et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2019)
Optimizing oncolytic virotherapy in cancer treatment
Kevin Harrington et al.
NATURE REVIEWS DRUG DISCOVERY (2019)
Codon bias confers stability to human mRNAs
Fabian Hia et al.
EMBO REPORTS (2019)
Oncolytic adenovirus programmed by synthetic gene circuit for cancer immunotherapy
Huiya Huang et al.
NATURE COMMUNICATIONS (2019)
Preclinical And Clinical Development Of Oncolytic Adenovirus For The Treatment Of Malignant Glioma
Juri Kiyokawa et al.
ONCOLYTIC VIROTHERAPY (2019)
Armed oncolytic viruses: A kick-start for anti-tumor immunity
J. F. de Graaf et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2018)
TNFa and IL-2 armed adenoviruses enable complete responses by anti-PD-1 checkpoint blockade
V. Cervera-Carrascon et al.
ONCOIMMUNOLOGY (2018)
Designing and building oncolytic viruses
Justin Maroun et al.
FUTURE VIROLOGY (2017)
Toxicological and bio-distribution profile of a GM-CSF-expressing, double-targeted, chimeric oncolytic adenovirus ONCOS-102-Support for clinical studies on advanced cancer treatment
Lukasz Kuryk et al.
PLOS ONE (2017)
Oncolytic adenovirus expressing relaxin (YDC002) enhances therapeutic efficacy of gemcitabine against pancreatic cancer
Kyung Hee Jung et al.
CANCER LETTERS (2017)
Phase I study with ONCOS-102 for the treatment of solid tumors - an evaluation of clinical response and exploratory analyses of immune markers
Tuuli Ranki et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2016)
Codon optimization of the adenoviral fiber negatively impacts structural protein expression and viral fitness
Eneko Villanueva et al.
SCIENTIFIC REPORTS (2016)
Preclinical toxicology of oncolytic adenovirus-mediated cytotoxic and interleukin-12 gene therapy for prostate cancer
Svend O. Freytag et al.
MOLECULAR THERAPY-ONCOLYTICS (2015)
Safety and Efficacy of VCN-01, an Oncolytic Adenovirus Combining Fiber HSG-Binding Domain Replacement with RGD and Hyaluronidase Expression
Alba Rodriguez-Garcia et al.
CLINICAL CANCER RESEARCH (2015)
iRGD tumor-penetrating peptide-modified oncolytic adenovirus shows enhanced tumor transduction, intratumoral dissemination and antitumor efficacy
C. Puig-Saus et al.
GENE THERAPY (2014)
Efficacy of oncolytic adenovirus expressing suicide genes and interleukin-12 in preclinical model of prostate cancer
S. O. Freytag et al.
GENE THERAPY (2013)
Improved systemic antitumor therapy with oncolytic adenoviruses by replacing the fiber shaft HSG-binding domain with RGD
J. J. Rojas et al.
GENE THERAPY (2012)
CAIcal:: A combined set of tools to assess codon usage adaptation
Pere Puigbo et al.
BIOLOGY DIRECT (2008)
Re-engineering adenovirus vector systems to enable high-throughput analyses of gene function
Richard J. Stanton et al.
BIOTECHNIQUES (2008)
A novel type of splicing enhancer regulating adenovirus pre-mRNA splicing
O Mühlemann et al.
MOLECULAR AND CELLULAR BIOLOGY (2000)
Share Paper
